GCM
Glenview Capital Management’s Takeda Pharmaceutical TAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-8,102,119
| Closed | -$133M | – | 61 |
|
|
2021
Q3 | $133M | Sell |
8,102,119
-1,013,402
| -11% | -$16.6M | 2.41% | 11 |
|
|
2021
Q2 | $153M | Sell |
9,115,521
-6,988,701
| -43% | -$118M | 2.54% | 9 |
|
|
2021
Q1 | $294M | Buy |
16,104,222
+843,710
| +6% | +$15.4M | 4.98% | 6 |
|
|
2020
Q4 | $278M | Sell |
15,260,512
-1,528,077
| -9% | -$27.8M | 6.37% | 3 |
|
|
2020
Q3 | $300M | Buy |
16,788,589
+593,279
| +4% | +$10.6M | 9.4% | 2 |
|
|
2020
Q2 | $290M | Sell |
16,195,310
-3,761,689
| -19% | -$67.4M | 8.01% | 2 |
|
|
2020
Q1 | $303M | Sell |
19,956,999
-10,625,722
| -35% | -$161M | 8.24% | 1 |
|
|
2019
Q4 | $603M | Buy |
30,582,721
+3,138,875
| +11% | +$61.9M | 5.28% | 5 |
|
|
2019
Q3 | $472M | Buy |
27,443,846
+1,013,018
| +4% | +$17.4M | 4.97% | 5 |
|
|
2019
Q2 | $468M | Buy |
26,430,828
+318,168
| +1% | +$5.63M | 4.24% | 8 |
|
|
2019
Q1 | $532M | Buy |
+26,112,660
| New | +$532M | 4.75% | 7 |
|